This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Insulin receptor
From Proteopedia
| Line 1: | Line 1: | ||
<StructureSection load='3bu5' size='350' side='right' caption='Structure of human insulin receptor tyrosine kinase catalytic domain complex with insulin receptor substrate 2 peptide (cyan), Mg+2 ion (green) and ATP (PDB entry [[3bu5]])' scene='51/516456/Cv/1'> | <StructureSection load='3bu5' size='350' side='right' caption='Structure of human insulin receptor tyrosine kinase catalytic domain complex with insulin receptor substrate 2 peptide (cyan), Mg+2 ion (green) and ATP (PDB entry [[3bu5]])' scene='51/516456/Cv/1'> | ||
== Function == | == Function == | ||
| - | '''Insulin receptor''' (IR) is a transmembrane receptor activated by insulin, insulin-like growth factor I and II<ref>PMID:8141246</ref>. The IR is a dimer where each monomer contains 8 distinct domains. The β-chain contains a tyrosine kinase catalytic domain (TK). For more details see [[Student Projects for UMass Chemistry 423 Spring 2012-1]].<br /> | + | '''Insulin receptor''' (IR) is a transmembrane receptor activated by insulin, insulin-like growth factor I and II<ref>PMID:8141246</ref>. The IR is a dimer where each monomer contains 8 distinct domains. Residues 28-337 are the L1-CR domain. The β-chain contains a tyrosine kinase catalytic domain (TK) residues 1005-1310. For more details see [[Student Projects for UMass Chemistry 423 Spring 2012-1]].<br /> |
== Disease == | == Disease == | ||
| Line 23: | Line 23: | ||
[[4xst]] – hIR L1-CR domains <br /> | [[4xst]] – hIR L1-CR domains <br /> | ||
[[2mfr]] – hIR transmembrane domain - NMR<br /> | [[2mfr]] – hIR transmembrane domain - NMR<br /> | ||
| + | [[5j3h]] – hIR L1-CR domains + antibody + peptide<br /> | ||
| + | [[4xss]] – hIR L1-CR domains + insulin-like growth factor 1<br /> | ||
[[4xlv]] - hIR TK domain (mutant) + ATP derivative<br /> | [[4xlv]] - hIR TK domain (mutant) + ATP derivative<br /> | ||
[[1ir3]] - hIR TK domain (mutant) + ATP analog + peptide<br /> | [[1ir3]] - hIR TK domain (mutant) + ATP analog + peptide<br /> | ||
| Line 33: | Line 35: | ||
[[2auh]] – hIR TK domain + growth factor receptor-bound protein 14<br /> | [[2auh]] – hIR TK domain + growth factor receptor-bound protein 14<br /> | ||
[[2b4s]] - hIR TK domain + tyrosine-protein phosphatase<br /> | [[2b4s]] - hIR TK domain + tyrosine-protein phosphatase<br /> | ||
| - | [[1rqq]] – hIR TK domain (mutant) + adaptor protein PS | + | [[1rqq]] – hIR TK domain (mutant) + adaptor protein PS<br /> |
| + | [[6ce7]], [[6ce9]], [[6ceb]] – hIR + insulin <br /> | ||
| + | [[5kqv]] – hIR + insulin + antibody<br /> | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:01, 22 July 2018
| |||||||||||
3D structures of insulin receptor
1irk – hIR TK domain – human
1i44, 1p14 – hIR TK domain (mutant)
2hr7 – hIR domains 1-3
4xst – hIR L1-CR domains
2mfr – hIR transmembrane domain - NMR
5j3h – hIR L1-CR domains + antibody + peptide
4xss – hIR L1-CR domains + insulin-like growth factor 1
4xlv - hIR TK domain (mutant) + ATP derivative
1ir3 - hIR TK domain (mutant) + ATP analog + peptide
3bu5, 3bu6 - hIR TK domain + ATP + peptide
3bu3 - hIR TK domain + peptide
1gag, 2z8c - hIR TK domain (mutant) + peptide
3ekk, 3ekn, 4ibm, 5hhw - hIR TK domain (mutant) + inhibitor
3eta, 5e1s - hIR TK domain + inhibitor
4zxb - hIR ectodomain (mutant) + antibody
2auh – hIR TK domain + growth factor receptor-bound protein 14
2b4s - hIR TK domain + tyrosine-protein phosphatase
1rqq – hIR TK domain (mutant) + adaptor protein PS
6ce7, 6ce9, 6ceb – hIR + insulin
5kqv – hIR + insulin + antibody
References
- ↑ Lee J, Pilch PF. The insulin receptor: structure, function, and signaling. Am J Physiol. 1994 Feb;266(2 Pt 1):C319-34. PMID:8141246
- ↑ Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 2008 Feb;114(1):23-37. doi: 10.1080/13813450801969715 . PMID:18465356 doi:http://dx.doi.org/10.1080/13813450801969715
- ↑ Wu J, Tseng YD, Xu CF, Neubert TA, White MF, Hubbard SR. Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat Struct Mol Biol. 2008 Mar;15(3):251-8. Epub 2008 Feb 17. PMID:18278056 doi:10.1038/nsmb.1388
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, R. Jeremy Johnson, Karsten Theis, Jaime Prilusky
